Background
==========

The cysteinyl leukotrienes (CysLTs) are lipid mediators that have been implicated in the pathogenesis of allergic rhinitis. Pharmacological studies using CysLTs indicate two classes of receptors named CysLT~1~ and CysLT~2~ receptor exist. The former is sensitive to the CysLT~1~ receptor antagonists currently used to treat asthma and allergic rhinitis. We have previously reported the localization of CysLT~1~ receptor by using immunohistochemistry and in situ hybridization. To clarify the expression of CysLT~2~ receptor in human nasal mucosa, we investigated the expression and the localization of CysLT~2~ receptor in human nasal mucosa by means of Western blot analysis and immunohistochemistry.

Methods
=======

Human turbinates were obtained by turbinectomy from 12 patients with nasal obstruction refractory to medical therapy. CysLT~2~ receptor expression on nasal mucosa was studied by Western blot analysis and immunohistochemistry. Also, to investigate the possible modulation of CysLT~2~ receptor expression, human umbilical vein endothelial cells (HUVECs) were stimulated with IL-4 or IL-13, and CysLT~2~ receptor expression were evaluated by Western blot analysis.

Results
=======

About 40kDa band was detected in human turbinates by western blot analysis using anti-CysLT~2~ receptor antibody. The expression level of CysLT~2~ receptor protein was marked in patients with nasal allergy than in patients with non-allergic rhinitis. The immunohistochemical study revealed that both vascular endothelial cells and vascular smooth muscles showed intense immunoreactivity for CysLT~2~ receptor. IL-13 enhanced the levels of CysLT2 receptor protein in HUVECs.

Conclusions
===========

The results suggest a primary role for CysLT~2~ receptor as the vascular responses in upper respiratory tract,and vascular CysLT~2~receptor expression can be regulated by Th2 cytokines.
